Chronic inflammatory demyelinating polyneuropathy (CIDP)

8 total trials 4 recruiting

Filter these 8 trials by phase, country, sponsor and more.

Open in Search →

A study to assess the efficacy and safety of empasiprubart in adults with CIDP Recruiting

2025-520805-10-00 5 2026-03-12
A study to assess efficacy and safety of empasiprubart versus IVIg in adults with CIDP ("emvigorate") Recruiting

2024-520097-36-00 5 2026-01-07
A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 4 2025-11-28
Rituximab-induced remission in CIDP (ReCIX study) Recruiting

2024-512506-25-00 5 2024-10-07
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP Ended

2024-515386-34-00 4 2025-05-29
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP Ended

2024-518364-12-00 4 2025-05-09
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. Ended

2024-512646-42-00 4 2023-06-27
Subcutaneous Immunoglobulin in De-novo CIDP - SIDEC Ended

2024-515898-96-01 11

Showing 1–8 of 8 trials